Erlacher L, Ng C K, Ullrich R, Krieger S, Luyten F P
National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, USA.
Arthritis Rheum. 1998 Feb;41(2):263-73. doi: 10.1002/1529-0131(199802)41:2<263::AID-ART10>3.0.CO;2-5.
To investigate the effects of the cartilage-derived morphogenetic proteins (CDMPs) in an in vitro cartilage explant model that mimics the chondrocytic response to matrix depletion, and to demonstrate their presence in articular cartilage.
Adult bovine articular cartilage and postmortem specimens from adult human donors with and without osteoarthritic (OA) lesions were stained by immunohistochemistry using polyclonal antibodies specific for CDMP-1 and CDMP-2. Extracts of bovine articular cartilage were analyzed by Western blotting for the presence of the CDMPs. Bovine articular cartilage explants were depleted of their matrix by trypsin digestion, followed by a 7-day culture period in a chemically defined serum-free basal medium (BM), with or without recombinant CDMPs 1 and 2. The metabolic activity of chondrocytes was measured by 35S-sulfate incorporation into macromolecules. Newly synthesized proteoglycans (PGs) were analyzed using Sephacryl S-500 HR gel chromatography. The expression levels of the messenger RNA (mRNA) for chondrogenic markers were investigated by Northern analysis.
CDMP-1 and CDMP-2 were detected in both bovine and human healthy and OA articular cartilage. Treatment of matrix-depleted cartilage explants with CDMPs 1 and 2 increased equally the incorporation of 35S-sulfate into PGs compared with tissue maintained in BM. Gel chromatography analysis indicated that aggrecan was the predominant PG species. Northern blot analysis showed that the expression of link protein, type II collagen, and aggrecan mRNA transcripts was not modulated by CDMP treatment.
This study shows the presence of CDMP-1 and CDMP-2 in adult bovine and human articular cartilage. In addition, our in vitro data indicate that CDMPs 1 and 2 stimulate the metabolic activity of articular chondrocytes. Therefore, these signaling molecules may be contributing to the maintenance of the integrity of the joint surface.
在模拟软骨细胞对基质耗竭反应的体外软骨外植体模型中研究软骨源性形态发生蛋白(CDMPs)的作用,并证明它们在关节软骨中的存在。
使用针对CDMP-1和CDMP-2的多克隆抗体,通过免疫组织化学对成年牛关节软骨以及有无骨关节炎(OA)病变的成年人类供体的死后标本进行染色。通过蛋白质印迹法分析牛关节软骨提取物中CDMPs的存在情况。通过胰蛋白酶消化去除牛关节软骨外植体的基质,然后在化学成分明确的无血清基础培养基(BM)中培养7天,添加或不添加重组CDMPs 1和2。通过将35S-硫酸盐掺入大分子中来测量软骨细胞的代谢活性。使用Sephacryl S-500 HR凝胶色谱法分析新合成的蛋白聚糖(PGs)。通过Northern分析研究软骨生成标志物信使核糖核酸(mRNA)的表达水平。
在牛和人类健康及OA关节软骨中均检测到CDMP-1和CDMP-2。与在BM中培养的组织相比,用CDMPs 1和2处理基质耗竭的软骨外植体可同等程度地增加35S-硫酸盐掺入PGs中的量。凝胶色谱分析表明聚集蛋白聚糖是主要的PG种类。Northern印迹分析表明,连接蛋白、II型胶原蛋白和聚集蛋白聚糖mRNA转录物的表达不受CDMP处理的调节。
本研究表明CDMP-1和CDMP-2存在于成年牛和人类关节软骨中。此外,我们的体外数据表明CDMPs 1和2刺激关节软骨细胞的代谢活性。因此,这些信号分子可能有助于维持关节表面的完整性。